Nitric Oxide During Bypass for Arterial Switch Operation
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.
Also called NCT03661385
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 300 participants
- Registry
-
NCT03661385
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Australia, Canada, Indonesia, Malaysia
- Registry status
- Completed
Technical summary
Registry record NCT03661385. Randomized; quadruple masking; primary purpose prevention. Start 2018-07-11 (actual); primary completion 2022-03-23 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Nitric Oxide During Bypass for Arterial Switch Operation
- Acronym
- NASO
- Condition
- Low Cardiac Output Syndrome
- Condition
- Transposition of Great Vessels
- Intervention (Drug)
- Nitric Oxide
- Lead sponsor
- Murdoch Childrens Research Institute
Record details
- Record id
cardio:ct-nct03661385- Content hash
a380e12dbc46f91e5be3121996fe28fe405d0b199dd0e2a76559069920cfc6fa